Lack of leptin suppression in response to hypersecretion of catecholamines in pheochromocytoma patients.
Leptin is a major regulator of body weight and energy balance and is subject to a variety of regulatory inputs. From several previous studies, catecholamines have been suggested to exert an inhibitory influence on leptin production in animals. In the present study, we analyzed leptin levels in relation to catecholamine hypersecretion in 27 human pheochromocytoma patients. A 10-fold increase in circulating norepinephrine (P < .0001) did not result in suppression of plasma leptin in the patients compared with normal controls (median and interquartile range, 4.3 ng/mL [2.4 to 6.8] v 2.2 ng/mL [1.9 to 3.0] in men and 18.6 [12.3 to 27.0] v 11.4 [10.1 to 15.9] in women). Correlation analysis indicated a significant association of leptin with epinephrine in normal subjects (r = -.81, P < .0001), but not in pheochromocytoma patients. Leptin was not related to norepinephrine in either group. In conclusion, our data suggest that a chronic elevation of catecholamines does not cause suppression of leptin secretion in patients with pheochromocytoma. This lack of effect may be attributable to the development of tolerance of adipose tissue leptin production to catecholamines.
Böttner
A
A
Department of Internal Medicine III, University of Leipzig, Germany. med93cvj@studserv.uni-leipzig.de
Eisenhofer
G
G
Torpy
D J
DJ
Ehrhart-Bornstein
M
M
Keiser
H R
HR
Chrousos
G P
GP
Bornstein
S R
SR
D000310:Adrenal Gland Neoplasms / Q000378:metabolism*; D000328:Adult; D015992:Body Mass Index; D001835:Body Weight / Q000502:physiology; D004837:Epinephrine / Q000097:blood / Q000378:metabolism*; D005260:Female; D006801:Humans; D020738:Leptin; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000097:blood / Q000378:metabolism*; D010673:Pheochromocytoma / Q000378:metabolism*; D011506:Proteins / Q000378:metabolism*; D012016:Reference Values
D020738:Leptin; D011506:Proteins; D009638:Norepinephrine; D004837:Epinephrine